|
1
|
Symonds RP, Gourley C, Davidson S, Carty
K, McCartney E, Rai D, Banerjee S, Jackson D, Lord R, McCormack M,
et al: Cediranib combined with carboplatin and paclitaxel in
patients with metastatic or recurrent cervical cancer (CIRCCa): A
randomised, double-blind, placebo-controlled phase 2 trial. Lancet
Oncol. 16:1515–1524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Braicu EI, Fotopoulou C, Chekerov R,
Richter R, Blohmer J, Kümmel S, Stamatian F, Yalcinkaya I, Mentze
M, Lichtenegger W and Sehouli J: Role of serum concentration of
VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer:
Results of a companion protocol of the randomized, NOGGO-AGO phase
III adjuvant trial of simultaneous cisplatin-based
radiochemotherapy vs. carboplatin and paclitaxel containing
sequential radiotherapy. Cytokine. 61:755–758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burtness B, Bourhis JP, Vermorken JB,
Harrington KJ and Cohen EE: Afatinib versus placebo as adjuvant
therapy after chemoradiation in a double-blind, phase III study
(LUX-Head & Neck 2) in patients with primary unresected,
clinically intermediate-to-high-risk head and neck cancer: Study
protocol for a randomized controlled trial. Trials. 15:4692014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muwonge R, Wesley RS, Nene BM, Shastri SS,
Jayant K, Malvi SG, Thara S and Sankaranarayanan R: Evaluation of
cytology and visual triage of human papillomavirus-positive women
in cervical cancer prevention in India. Int J Cancer.
134:2902–2909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeCarlo CA, Rosa B, Jackson R, Niccoli S,
Escott NG and Zehbe I: Toll-like receptor transcriptome in the
HPV-positive cervical cancer microenvironment. Clin Dev Immunol.
2012:7858252012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Werner J, Decarlo CA, Escott N, Zehbe I
and Ulanova M: Expression of integrins and Toll-like receptors in
cervical cancer: Effect of infectious agents. Innate Immun.
18:55–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Cheng FW, Wang F, Jia B, Luo X and
Zhang SQ: The activation of TLR7 regulates the expression of VEGF,
TIMP1, MMP2, IL-6, and IL-15 in Hela cells. Mol Cell Biochem.
389:43–49. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhan Z, Xie X, Cao H, Zhou X, Zhang XD,
Fan H and Liu Z: Autophagy facilitates TLR4- and TLR3-triggered
migration and invasion of lung cancer cells through the promotion
of TRAF6 ubiquitination. Autophagy. 10:257–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xiao J, Guo Q, Wang X, Xie F, Zhang H and
Sui L: Study on the expression and signification of TLR4/NO pathway
in cervical tumorigenesis with high risk HPV infection. Zhonghua Fu
Chan Ke Za Zhi. 50:41–47. 2015.(In Chinese). PubMed/NCBI
|
|
10
|
He A, Ji R, Shao J, He C, Jin M and Xu Y:
TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-κB activation contribute
to the anti-inflammatory effect of V8 in LPS-induced human cervical
cancer SiHa cells. Inflammation. 39:172–181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kirchheiner K, Nout RA, Czajka-Pepl A,
Ponocny-Seliger E, Sturdza AE, Dimopoulos JC, Dörr W and Pötter R:
Health related quality of life and patient reported symptoms before
and during definitive radio (chemo)therapy using image-guided
adaptive brachytherapy for locally advanced cervical cancer and
early recovery-a mono-institutional prospective study. Gynecol
Oncol. 136:415–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tomomura M, Suzuki R, Shirataki Y,
Sakagami H, Tamura N and Tomomura A: Rhinacanthin C inhibits
osteoclast differentiation and bone resorption: Roles of
TRAF6/TAK1/MAPKs/NF-κB/NFATc1 signaling. PLoS One. 10:e01301742015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He W and Cronstein BN: Adenosine A1
receptor regulates osteoclast formation by altering TRAF6/TAK1
signaling. Purinergic Signal. 8:327–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bai C, Yang X, Zou K, He H, Wang J, Qin H,
Yu X, Liu C, Zheng J, Cheng F and Chen J: Anti-proliferative effect
of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells
by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB
activation. Naunyn Schmiedebergs Arch Pharmacol. 389:573–584. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng KW, Yu Q, Liao LX, Song FJ, Lv HN,
Jiang Y and Tu PF: Anti-neuroinflammatory effect of MC13, a novel
coumarin compound from condiment murraya, through inhibiting
lipopolysaccharide-induced TRAF6-TAK1-NF-κB, P38/ERK MAPKS and
Jak2-Stat1/Stat3 pathways. J Cell Biochem. 116:1286–1299. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nees M, Geoghegan JM, Hyman T, Frank S,
Miller L and Woodworth CD: Papillomavirus type 16 oncogenes
downregulate expression of interferon-responsive genes and
upregulate proliferation-associated and NF-kappaB-responsive genes
in cervical keratinocytes. J Virol. 75:4283–4296. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Gu L, Li Z and Zhou M: Translation
of TRAF1 is regulated by IRES-dependent mechanism and stimulated by
vincristine. Nucleic Acids Res. 38:4503–4513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Capalbo G, Mueller-Kuller T, Koschmieder
S, Klein HU, Ottmann OG, Hoelzer D and Scheuring UJ:
Characterization of ZC3H15 as a potential TRAF-2-interacting
protein implicated in the NFκB pathway and overexpressed in AML.
Int J Oncol. 43:246–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Y, Fu H, Zhang H, Huang H, Chen M,
Zhang L, Yang H and Qin D: Cyclin D1 (CCND1) G870A polymorphisms
and cervical cancer susceptibility: A meta-analysis based on ten
case-control studies. Tumour Biol. 35:6913–6918. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ni HJ, Chang YN, Kao PH, Chai SP, Hsieh
YH, Wang DH and Fong JC: Depletion of SUMO ligase hMMS21 impairs G1
to S transition in MCF-7 breast cancer cells. Biochim Biophys Acta.
1820:1893–1900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Bai M, Ning C, Xie B, Zhang J,
Liao H, Xiong J, Tao X, Yan D, Xi X, et al: Gankyrin facilitates
follicle-stimulating hormone-driven ovarian cancer cell
proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
Oncogene. 35:2506–2517. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan Z, Cui H, Yu H, Ji Q, Kang L, Han B,
Wang J, Dong Q, Li Y, Yan Z, et al: MiR-125a promotes paclitaxel
sensitivity in cervical cancer through altering STAT3 expression.
Oncogenesis. 5:e1972016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang P, Yang B, Yao YY, Zhong LX, Chen
XY, Kong QY, Wu ML, Li C, Li H and Liu J: PIAS3, SHP2 and SOCS3
expression patterns in cervical cancers: Relevance with activation
and resveratrol-caused inactivation of STAT3 signaling. Gynecol
Oncol. 139:529–535. 2015. View Article : Google Scholar : PubMed/NCBI
|
